We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Joined at the hip

5 November 2006

Buying the US orthopedics group seems strategically sound. But it doesn t obviously add value. What value it does add comes from gearing up. Unless it can pay less or find more synergies, S&N should probably gear up and return cash. Otherwise it risks being snapped up itself.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)